distal ureterectomy

PROCEDURE2 trials

Sponsors

Xiangya Hospital of Central South University, Tianjin Medical University Second Hospital

Conditions

High-Grade Upper Tract Urothelial CarcinomaKidney-sparingNab-paclitaxelNeoadjuvant TherapyPD-1 InhibitorTislelizumabUreteral Cancer

Phase 2

Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC

CompletedNCT02876861

Xiangya Hospital of Central South UniversityHigh-Grade Upper Tract Urothelial Carcinoma

Start: 2014-02-28End: 2022-08-31Updated: 2022-11-10

Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer

RecruitingNCT07125547

Tianjin Medical University Second HospitalKidney-sparing, Nab-paclitaxel, Neoadjuvant Therapy +3

Start: 2025-07-05End: 2030-12-30Target: 35Updated: 2025-08-15